The biotechnology industry stands at a pivotal point, driven by rapid technological advancements and shifting market dynamics. The past few years have been transformative, with groundbreaking innovations reshaping the landscape of healthcare, drug development, and beyond.
Given the industry’s bright prospects, it could be wise to monitor fundamentally strong biotech stocks Harmony Biosciences Holdings, Inc. (HRMY), Illumina, Inc. (ILMN), and Compugen Ltd. (CGEN) for potential gains.
